Skip to main content

Advertisement

Table 5 This shows the number of respondents that attended their primary care provider with symptoms from the NET

From: Delays and routes to diagnosis of neuroendocrine tumours

  Primary Care Secondary Care
Site of NET Respondents % seen by GP Mean No. times seen by GP Mean time GP investigated (months) % seen in clinic Mean No. times seen in clinic Mean time clinic investigated (months)
Lung 51 73% 14 44 55% 3 4
Pancreas 52 73% 8 33 50% 4 21
Small Bowel 86 86% 10 40 62% 3 11
All/(mean) 257 (80%) (11) (37) (58%) (3) (17)
  1. The number of visits related to the GP and also secondary care if referred via their GP. The final column encompasses all respondents that completed this part of the questionnaire and not separated by tumour site